{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:58Z","timestamp":1792796818770,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cca.2014.07.039","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T01:46:09Z","timestamp":1407375969000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Association between serum uric acid and inflammation in rheumatoid arthritis: Perspective on lowering serum uric acid of leflunomide"],"prefix":"10.1016","volume":"438","author":[{"given":"Jung-Yoon","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.07.039_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2014.07.039_bb0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.07.039_bb0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.07.039_bb0020","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI40124","article-title":"Uric acid promotes an acute inflammatory response to sterile cell death in mice","volume":"120","author":"Kono","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.07.039_bb0025","doi-asserted-by":"crossref","first-page":"e19901","DOI":"10.1371\/journal.pone.0019901","article-title":"Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study","volume":"6","author":"Lyngdoh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.07.039_bb0030","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.07.039_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.07.039_bb0040","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2014.07.039_bb0045","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","article-title":"Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans","volume":"273","author":"R\u00fcckemann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.07.039_bb0050","first-page":"1016","article-title":"Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides","volume":"14","author":"Cao","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cca.2014.07.039_bb0055","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P","article-title":"Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis","volume":"42","author":"Weinblatt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.07.039_bb0060","first-page":"663","article-title":"Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1\u03b2 and metalloproteinases","volume":"9","author":"Deage","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cca.2014.07.039_bb0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/39.6.655","article-title":"A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis","volume":"39","author":"Emery","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2014.07.039_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.rhu.0000081470.31167.8b","article-title":"Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis","volume":"9","author":"Perez-Ruiz","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.cca.2014.07.039_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jbspin.2013.10.008","article-title":"The hypouricemiant effect of leflunomide","volume":"81","author":"Arida","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cca.2014.07.039_bb0080","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/annrheumdis-2011-201027","article-title":"No impact of serum uric acid on the outcome of recent-onset arthritis","volume":"71","author":"Luczak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.07.039_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.07.039_bb0090","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.transproceed.2005.08.042","article-title":"Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients","volume":"37","author":"Kanbay","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cca.2014.07.039_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cca.2014.07.039_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.07.039_bb0105","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cca.2014.07.039_bb0110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/ard.2007.086264","article-title":"Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance","volume":"68","author":"Kis","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.07.039_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00228-010-0916-0","article-title":"Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level","volume":"67","author":"Kim","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cca.2014.07.039_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cca.2005.09.002","article-title":"Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography","volume":"365","author":"Kand'\u00e1r","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.07.039_bb0125","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.07.039_bb0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15257770902736400","article-title":"Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress","volume":"28","author":"Gersch","year":"2009","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T16:56:23Z","timestamp":1565715383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":26,"alternative-id":["S0009898114003350"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.07.039","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between serum uric acid and inflammation in rheumatoid arthritis: Perspective on lowering serum uric acid of leflunomide","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}